|
시장보고서
상품코드
2003637
흉막 생검 시장 규모, 점유율, 성장 분석 : 생검 방법별, 제품 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2026-2033년)Pleural Biopsy Market Size, Share, and Growth Analysis, By Biopsy Techniques (CT-guided Biopsy, Ultrasound-guided Biopsy), By Product Types (Biopsy Needles, Biopsy Kits), By Applications, By End Users, By Region - Industry Forecast 2026-2033 |
||||||
세계의 흉막 생검 시장 규모는 2024년에 3억 3,040만 달러로 평가되었으며, 2025년 3억 5,088만 달러에서 2033년까지 5억 6,775만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 6.2%로 성장할 것으로 전망됩니다.
세계 흉막 생검 시장은 악성 흉막염, 결핵, 중피종과 같은 질병의 진단에 필수적인 조직병리학적 및 분자학적 분석을 위해 흉막강에서 조직을 채취하는 것을 목적으로 하는 기구, 소모품 및 서비스를 포함합니다. 이러한 질환의 유병률 증가와 최소침습적 기술로의 전환이 시장 성장을 주도하고 있습니다. 임상의들은 진단의 정확도를 높이기 위해 CT 유도하 코어 생검이나 흉강경 접근법을 점점 더 많이 채택하고 있습니다. 냉동생검, 첨단 영상 진단 기술 등의 기술 발전으로 맞춤형 치료 옵션이 가능해지면서 고품질 흉막 조직에 대한 수요가 증가하고 있습니다. 또한 인공지능(AI)은 이미지 자동 분석, 바늘 삽입 위치 유도 및 슬라이드 해석 최적화를 통해 진단 정확도를 향상시킵니다. 이러한 진단 기술의 발전과 신흥 시장의 미충족 수요는 역동적인 헬스케어 분야의 공급업체들에게 새로운 비즈니스 기회와 전략적 제휴의 기회를 창출하고 있습니다.
세계 흉막 생검 시장의 성장요인
세계 흉막 생검 시장은 영상 진단 및 내비게이션 기술의 발전에 의해 크게 견인되고 있습니다. 이러한 기술은 흉막 병변의 위치 파악과 생검 시술의 유도 정확도를 크게 향상시켰습니다. 이러한 정확도의 비약적인 향상으로 생검 시 불확실성이 줄어들어 임상의의 확신이 높아졌습니다. 그 결과, 이러한 혁신 기술은 특히 작거나 진단이 어려운 병변에 대한 보다 표적화된 접근을 가능하게 하고, 다양한 치료 시설에서 안전성과 재현성을 향상시키는 최소침습적 시술을 촉진하고 있습니다. 또한, 가시성 향상은 중재적 호흡기 전문의와 흉부외과 전문의의 채택을 촉진하고, 보완적인 생검 장비에 대한 투자를 촉진하고, 멀티모달 워크플로우의 통합을 촉진하여 궁극적으로 흉막 생검 솔루션에 대한 수요를 증가시키고 있습니다.
세계 흉막 생검 시장의 억제요인
전 세계 흉막 생검 시장은 불충분한 보험급여 정책과 시술 비용 상승으로 인해 생검 기술의 보급을 저해하는 심각한 문제에 직면해 있습니다. 이러한 재정적 장벽은 의료 기관이 필요한 투자를 주저하게 만들고, 특히 수익성이 제한적인 환경에서 이러한 시술의 일상적인 시행을 감소시키고 있습니다. 비용에 대한 불확실성은 조달 과정을 지연시키고, 교육 및 장비에 대한 자금 배분 기회를 제한할 수 있습니다. 또한, 예산이 제한된 의료기관은 보수적인 치료법을 선택하거나 환자를 전문 기관에 의뢰하는 경향이 있으며, 이는 궁극적으로 시장 성장에 영향을 미치고 다양한 의료 환경에서 혁신적인 생검 장치의 도입을 지연시킬 수 있습니다.
세계 흉막 생검 시장 동향
의료 서비스 제공자가 환자의 편안함과 회복 기간 단축을 우선시하는 가운데, 전 세계 흉막 생검 시장은 최소침습적 기술로 크게 전환하고 있습니다. 영상 유도하 코어 니들 생검과 흉강경 생검은 그 효율성과 불편함 감소로 인해 점점 더 많은 지지를 받고 있으며, 병원들은 이러한 시술을 용이하게 하는 첨단 장비에 투자하고 있습니다. 제조업체들은 바늘의 디자인과 영상기술의 혁신을 추진하는 한편, 임상 현장에 원활하게 도입될 수 있도록 교육 프로그램을 강화하기 위해 노력하고 있습니다. 이러한 추세는 기기 제조사와 의료진과의 협력을 촉진할 뿐만 아니라 제품의 차별화를 촉진하고, 다양한 의료 환경에서의 보급 확대와 진단 품질 향상으로 이어지고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 흉막 생검 시장 규모 : 생검 방법별
세계의 흉막 생검 시장 규모 : 제품 유형별
세계의 흉막 생검 시장 규모 : 용도별
세계의 흉막 생검 시장 규모 : 최종사용자별
세계의 흉막 생검 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.04.28Global Pleural Biopsy Market size was valued at USD 330.4 Million in 2024 and is poised to grow from USD 350.88 Million in 2025 to USD 567.75 Million by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).
The global pleural biopsy market encompasses instruments, consumables, and services aimed at extracting tissue from the pleural space for histopathological and molecular analysis, pivotal for diagnosing conditions like malignant pleural effusion, tuberculosis, and mesothelioma. The rising prevalence of these diseases and a shift towards minimally invasive techniques drive market growth. Clinicians increasingly adopt CT-guided core biopsies and thoracoscopic approaches for enhanced diagnostic precision. Technological advancements, including cryobiopsy and superior imaging, facilitate personalized treatment options, thereby heightening demand for quality pleural tissue. Furthermore, artificial intelligence enhances diagnostic accuracy through automated image analysis, guiding needle placement, and optimizing slide interpretation. This evolution in diagnostics, alongside unmet needs in emerging markets, fosters new commercial opportunities and strategic collaborations for suppliers in this dynamic healthcare sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pleural Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pleural Biopsy Market Segments Analysis
Global pleural biopsy market is segmented by biopsy techniques, product types, applications, end users and region. Based on biopsy techniques, the market is segmented into CT-guided Biopsy, Ultrasound-guided Biopsy and Bronchoscopy-assisted Biopsy. Based on product types, the market is segmented into Biopsy Needles, Biopsy Kits and Forceps. Based on applications, the market is segmented into Cancer Diagnosis and Infection Assessment. Based on end users, the market is segmented into Hospitals, Diagnostic Laboratories and Outpatient Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pleural Biopsy Market
The Global Pleural Biopsy market is significantly driven by advancements in imaging and navigation technologies, which have markedly improved the precision of locating pleural lesions and guiding biopsy procedures. This surge in accuracy diminishes uncertainties during biopsies, thereby enhancing clinician confidence. Consequently, these innovations allow for more targeted approaches, particularly for small or challenging lesions while promoting minimally invasive techniques that enhance safety and reproducibility across various treatment centers. Furthermore, improved visualization encourages greater adoption among interventional pulmonologists and thoracic surgeons, stimulates investment in complementary biopsy instruments, and fosters the integration of multimodal workflows, ultimately elevating the demand for pleural biopsy solutions.
Restraints in the Global Pleural Biopsy Market
The Global Pleural Biopsy market faces significant challenges due to insufficient reimbursement policies and elevated procedural costs, which hinder the widespread adoption of biopsy technologies. These financial barriers discourage healthcare institutions from making necessary investments and diminish the routine use of such procedures, especially in environments where profit margins are limited. The uncertainty surrounding costs can lead to delayed procurement processes, restricting opportunities for capital allocation towards training and equipment. Additionally, providers with limited budgets may prefer conservative treatment options or refer patients to specialized centers, ultimately impacting market growth and slowing the integration of innovative biopsy devices across various healthcare environments.
Market Trends of the Global Pleural Biopsy Market
The Global Pleural Biopsy market is witnessing a significant shift towards minimally invasive techniques, as healthcare providers prioritize patient comfort and faster recovery times. Image-guided core needle and thoracoscopic methods are increasingly favored for their efficiency and reduced discomfort, prompting hospitals to invest in advanced devices that facilitate these procedures. As manufacturers innovate in needle design and imaging technologies, they are also enhancing training programs to ensure seamless integration into clinical practice. This trend not only drives collaboration between device manufacturers and healthcare professionals but also encourages product differentiation, leading to broader adoption and improved diagnostic quality across diverse care environments.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Case Studies
Global Pleural Biopsy Market Size by Biopsy Techniques & CAGR (2026-2033)
- Market Overview
- CT-guided Biopsy
- Ultrasound-guided Biopsy
- Bronchoscopy-assisted Biopsy
Global Pleural Biopsy Market Size by Product Types & CAGR (2026-2033)
- Market Overview
- Biopsy Needles
- Biopsy Kits
- Forceps
Global Pleural Biopsy Market Size by Applications & CAGR (2026-2033)
- Market Overview
- Cancer Diagnosis
- Infection Assessment
Global Pleural Biopsy Market Size by End Users & CAGR (2026-2033)
- Market Overview
- Hospitals
- Diagnostic Laboratories
- Outpatient Clinics
Global Pleural Biopsy Market Size & CAGR (2026-2033)
- North America (Biopsy Techniques, Product Types, Applications, End Users)
- US
- Canada
- Europe (Biopsy Techniques, Product Types, Applications, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Biopsy Techniques, Product Types, Applications, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Biopsy Techniques, Product Types, Applications, End Users)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Biopsy Techniques, Product Types, Applications, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Varian Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bracco Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medline Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canon Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
